Misonix Inc (MSON) 12.47 $MSON
InsiderInsights.com Daily Round Up 2/12/15: PNNT, RENT, FSC, SC
InsiderInsights - at Seeking Alpha - Fri Feb 13, 10:46AM CST
SC: 22.11 (+0.38), PNNT: 9.40 (+0.16), CRR: 40.35 (+2.73), MSON: 12.47 (-0.40), RENT: 58.90 (+0.39), BBY: 39.11 (-0.08), CFX: 52.02 (+3.84), MLNK: 3.78 (+0.04), SERV: 30.48 (+0.33), GGP: 29.25 (-0.28), WIW: 11.29 (unch), CLIR: 7.26 (-0.08), FSC: 7.23 (+0.12), QLYS: 47.95 (+1.46), PLAY: 29.51 (-0.12), LEU: 4.20 (+0.32), ALJ: 13.06 (+0.50), MA: 87.14 (-0.38)
Insider Trading Alert - GPN, MSON And CMS Traded By Insiders
at The Street - Fri Feb 13, 9:38AM CST
Stocks with insider trader activity include GPN, MSON and CMS
CMS: 34.65 (-0.88), GPN: 91.86 (-0.32), MSON: 12.47 (-0.40)
Misonix (MSON) Upgraded From Hold to Buy
at The Street - Wed Feb 11, 2:00PM CST
Misonix (MSON) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
MSON: 12.47 (-0.40)
Misonix Up 10.6% Since SmarTrend Uptrend Call (MSON)
Comtex SmarTrend(R) - Tue Feb 10, 9:21AM CST
SmarTrend identified an Uptrend for Misonix (NASDAQ:MSON) on December 26th, 2014 at $12.61. In approximately 2 months, Misonix has returned 10.59% as of today's recent price of $13.94.
MSON: 12.47 (-0.40)
Misonix's (MSON) CEO Michael McManus on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 04, 9:09PM CST
MSON: 12.47 (-0.40)
MISONIX beats by $0.04
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 3:08PM CST
MSON: 12.47 (-0.40)
Misonix Acquires Remaining Exclusive BoneScalpel(TM) Business from Aesculap
PR Newswire - Tue Feb 03, 6:30AM CST
Misonix, Inc. (Nasdaq: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, has announced that it has entered into an agreement with Aesculap, Inc. to acquire back the rights to the remaining accounts, as of March 1, 2015, exclusively being managed by Aesculap for the Misonix BoneScalpel Ultrasonic Bone Cutting System.
MSON: 12.47 (-0.40)
Misonix, Inc. To Report Second Quarter Fiscal Year 2015 Financial Results On Wednesday, February 4, 2015
PR Newswire - Tue Jan 27, 3:53PM CST
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, announced today that it will report financial results for the second quarter fiscal year 2015 on Wednesday, February 4, 2015. The Company has scheduled a conference call that same day, Wednesday, February 4, 2015, at 4:30 pm ET to review the results.
MSON: 12.47 (-0.40)
Nasdaq stocks posting largest percentage increases
AP - Wed Jan 21, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
NFLX: 466.10 (+9.37), ASPS: 22.32 (+0.09), FLDM: 37.93 (-0.47), MCEP: 6.29 (+0.12), MSON: 12.47 (-0.40), SCYX: 9.48 (+0.07), ADHD: 6.92 (+0.73), GWGH: 6.64 (unch), FANG: 73.46 (+0.49), PDCE: 49.17 (+0.60)
Direction of Market Influences: Coverage Initiated on MFRI, Microvision, MISONIX, MKS Instruments and Mobile Mini
PR Newswire - Wed Dec 17, 7:15AM CST
Moments ago, Realtime Equities released new analyst updates concerning several important developing situations including MFRI (NASDAQ: MFRI), Microvision (NASDAQ: MVIS), MISONIX (NASADQ: MSON), MKS Instruments (NASDAQ: MKSI) and Mobile Mini (NASDAQ: MINI). Realtime Equities is the leader in realtime news, commentary and analysis - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
MVIS: 2.01 (+0.03), MSON: 12.47 (-0.40), MINI: 40.62 (-0.83), MFRI: 6.79 (+0.36), MKSI: 35.56 (-0.25)
BRIC Wound Debridement Devices Market Outlook to 2020: Key players covered include Smith & Nephew, Zimmer KG and Soring
M2 - Mon Dec 08, 5:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/vs8vxk/bric_wound) has announced the addition of the "BRIC Wound Debridement Devices Market Outlook to 2020" report to their offering. Our new report, "BRIC Wound Debridement Devices Market Outlook to 2020", provides key market data on the BRIC Wound Debridement Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Hydrosurgical Debridement Devices, Low Frequency Ultrasound Devices and Mechanical Debridement Pads. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Wound Debridement Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Key Topics Covered: 1 List of Tables 2 Introduction 3 Wound Debridement Devices Market, BRIC 4 Wound Debridement Devices Market, Brazil 5 Wound Debridement Devices Market, Russia 6 Wound Debridement Devices Market, India 7 Wound Debridement Devices Market, China 8 Overview of Key Companies in BRIC Wound Debridement Devices Market 9 Appendix Companies Mentioned: - Misonix, Inc. - Smith & Nephew Plc - Soring GmbH - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/vs8vxk/bric_wound
ZMH: 119.33 (+1.18), SNN: 35.82 (-0.28), MSON: 12.47 (-0.40)
Novel BoneScalpel Technique Published in Operative Neurosurgery
PR Newswire - Tue Dec 02, 6:30AM CST
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, announces a new clinical publication entitled, "Ultrasonic Total Uncinectomy: A Novel Technique for Complete Anterior Decompression of Cervical Nerve Roots," by Peyman Pakzaban, MD, Houston, Texas.
MSON: 12.47 (-0.40)
Misonix (MSON) Downgraded From Buy to Hold
at The Street - Mon Dec 01, 8:05AM CST
Misonix (MSON) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C.
MSON: 12.47 (-0.40)
Medical Devices From Misonix Are Game Changing For Patients, Surgeons, Hospitals - And Investors
John Leonard, CFA - at Seeking Alpha - Tue Nov 25, 9:26AM CST
MSON: 12.47 (-0.40)
SonicOne® Study Shows Improved Wound Healing In Patients with Peripheral Vascular Disease
PR Newswire - Thu Nov 20, 6:30AM CST
Misonix, Inc. (NasdaqGM: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications reported today that a SonicOne clinical paper was presented at the Canadian Association of Wound Care 20th Annual Conference in Toronto, Ontario held October 30 - November 2, 2014.
MSON: 12.47 (-0.40)
Misonix Trains Surgeons on the BoneScalpel(TM) at the 2014 North American Spine Society Annual Meeting
PR Newswire - Wed Nov 19, 2:19PM CST
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, announced that it trained more than 50 leading spine surgeons on the BoneScalpel system last week at the North American Spine Society ("NASS"
annual meeting in San Francisco, CA.
MSON: 12.47 (-0.40)
Clinical Paper on Treatment of Burns Highlights Effectiveness of Misonix SonicOne in Burn Center Operating Room
PR Newswire - Thu Nov 13, 1:41PM CST
Misonix, Inc. (NasdaqGM: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, participated in the 42nd Annual Eastern Great Lakes Burn Study Group Meeting in Pittsburgh, PA held October 16-17, 2014.
MSON: 12.47 (-0.40)
New Data Reports Reduction in Blood Loss With Misonix SonicOne® O.R. In Burn Patients
PR Newswire - Mon Nov 10, 12:39PM CST
Misonix, Inc. (NasdaqGM: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced that new data on SonicOne O.R. was presented at the American Burn Association's ("ABA" 2014 Western Regional Burn Conference in Las Vegas, NV, held November 6-9, 2014. The ABA and its more than 3,500 members promote and support burn-related research, education, care, rehabilitation and prevention.
MSON: 12.47 (-0.40)
Misonix (MSON) CEO Michael McManus on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 10:03PM CST
MSON: 12.47 (-0.40)
InsiderInsights.com Daily Round Up 2/12/15: PNNT, RENT, FSC, SC
InsiderInsights - at Seeking Alpha - Fri Feb 13, 10:46AM CST
SC: 22.11 (+0.38), PNNT: 9.40 (+0.16), CRR: 40.35 (+2.73), MSON: 12.47 (-0.40), RENT: 58.90 (+0.39), BBY: 39.11 (-0.08), CFX: 52.02 (+3.84), MLNK: 3.78 (+0.04), SERV: 30.48 (+0.33), GGP: 29.25 (-0.28), WIW: 11.29 (unch), CLIR: 7.26 (-0.08), FSC: 7.23 (+0.12), QLYS: 47.95 (+1.46), PLAY: 29.51 (-0.12), LEU: 4.20 (+0.32), ALJ: 13.06 (+0.50), MA: 87.14 (-0.38)
Insider Trading Alert - GPN, MSON And CMS Traded By Insiders
at The Street - Fri Feb 13, 9:38AM CST
Stocks with insider trader activity include GPN, MSON and CMS
CMS: 34.65 (-0.88), GPN: 91.86 (-0.32), MSON: 12.47 (-0.40)
Misonix (MSON) Upgraded From Hold to Buy
at The Street - Wed Feb 11, 2:00PM CST
Misonix (MSON) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
MSON: 12.47 (-0.40)
Misonix Up 10.6% Since SmarTrend Uptrend Call (MSON)
Comtex SmarTrend(R) - Tue Feb 10, 9:21AM CST
SmarTrend identified an Uptrend for Misonix (NASDAQ:MSON) on December 26th, 2014 at $12.61. In approximately 2 months, Misonix has returned 10.59% as of today's recent price of $13.94.
MSON: 12.47 (-0.40)
Misonix's (MSON) CEO Michael McManus on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 04, 9:09PM CST
MSON: 12.47 (-0.40)
MISONIX beats by $0.04
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 3:08PM CST
MSON: 12.47 (-0.40)
Misonix Acquires Remaining Exclusive BoneScalpel(TM) Business from Aesculap
PR Newswire - Tue Feb 03, 6:30AM CST
Misonix, Inc. (Nasdaq: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, has announced that it has entered into an agreement with Aesculap, Inc. to acquire back the rights to the remaining accounts, as of March 1, 2015, exclusively being managed by Aesculap for the Misonix BoneScalpel Ultrasonic Bone Cutting System.
MSON: 12.47 (-0.40)
Misonix, Inc. To Report Second Quarter Fiscal Year 2015 Financial Results On Wednesday, February 4, 2015
PR Newswire - Tue Jan 27, 3:53PM CST
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, announced today that it will report financial results for the second quarter fiscal year 2015 on Wednesday, February 4, 2015. The Company has scheduled a conference call that same day, Wednesday, February 4, 2015, at 4:30 pm ET to review the results.
MSON: 12.47 (-0.40)
Nasdaq stocks posting largest percentage increases
AP - Wed Jan 21, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
NFLX: 466.10 (+9.37), ASPS: 22.32 (+0.09), FLDM: 37.93 (-0.47), MCEP: 6.29 (+0.12), MSON: 12.47 (-0.40), SCYX: 9.48 (+0.07), ADHD: 6.92 (+0.73), GWGH: 6.64 (unch), FANG: 73.46 (+0.49), PDCE: 49.17 (+0.60)
Direction of Market Influences: Coverage Initiated on MFRI, Microvision, MISONIX, MKS Instruments and Mobile Mini
PR Newswire - Wed Dec 17, 7:15AM CST
Moments ago, Realtime Equities released new analyst updates concerning several important developing situations including MFRI (NASDAQ: MFRI), Microvision (NASDAQ: MVIS), MISONIX (NASADQ: MSON), MKS Instruments (NASDAQ: MKSI) and Mobile Mini (NASDAQ: MINI). Realtime Equities is the leader in realtime news, commentary and analysis - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
MVIS: 2.01 (+0.03), MSON: 12.47 (-0.40), MINI: 40.62 (-0.83), MFRI: 6.79 (+0.36), MKSI: 35.56 (-0.25)
BRIC Wound Debridement Devices Market Outlook to 2020: Key players covered include Smith & Nephew, Zimmer KG and Soring
M2 - Mon Dec 08, 5:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/vs8vxk/bric_wound) has announced the addition of the "BRIC Wound Debridement Devices Market Outlook to 2020" report to their offering. Our new report, "BRIC Wound Debridement Devices Market Outlook to 2020", provides key market data on the BRIC Wound Debridement Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Hydrosurgical Debridement Devices, Low Frequency Ultrasound Devices and Mechanical Debridement Pads. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Wound Debridement Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Key Topics Covered: 1 List of Tables 2 Introduction 3 Wound Debridement Devices Market, BRIC 4 Wound Debridement Devices Market, Brazil 5 Wound Debridement Devices Market, Russia 6 Wound Debridement Devices Market, India 7 Wound Debridement Devices Market, China 8 Overview of Key Companies in BRIC Wound Debridement Devices Market 9 Appendix Companies Mentioned: - Misonix, Inc. - Smith & Nephew Plc - Soring GmbH - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/vs8vxk/bric_wound
ZMH: 119.33 (+1.18), SNN: 35.82 (-0.28), MSON: 12.47 (-0.40)
Novel BoneScalpel Technique Published in Operative Neurosurgery
PR Newswire - Tue Dec 02, 6:30AM CST
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, announces a new clinical publication entitled, "Ultrasonic Total Uncinectomy: A Novel Technique for Complete Anterior Decompression of Cervical Nerve Roots," by Peyman Pakzaban, MD, Houston, Texas.
MSON: 12.47 (-0.40)
Misonix (MSON) Downgraded From Buy to Hold
at The Street - Mon Dec 01, 8:05AM CST
Misonix (MSON) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C.
MSON: 12.47 (-0.40)
Medical Devices From Misonix Are Game Changing For Patients, Surgeons, Hospitals - And Investors
John Leonard, CFA - at Seeking Alpha - Tue Nov 25, 9:26AM CST
MSON: 12.47 (-0.40)
SonicOne® Study Shows Improved Wound Healing In Patients with Peripheral Vascular Disease
PR Newswire - Thu Nov 20, 6:30AM CST
Misonix, Inc. (NasdaqGM: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications reported today that a SonicOne clinical paper was presented at the Canadian Association of Wound Care 20th Annual Conference in Toronto, Ontario held October 30 - November 2, 2014.
MSON: 12.47 (-0.40)
Misonix Trains Surgeons on the BoneScalpel(TM) at the 2014 North American Spine Society Annual Meeting
PR Newswire - Wed Nov 19, 2:19PM CST
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, announced that it trained more than 50 leading spine surgeons on the BoneScalpel system last week at the North American Spine Society ("NASS"
annual meeting in San Francisco, CA. MSON: 12.47 (-0.40)
Clinical Paper on Treatment of Burns Highlights Effectiveness of Misonix SonicOne in Burn Center Operating Room
PR Newswire - Thu Nov 13, 1:41PM CST
Misonix, Inc. (NasdaqGM: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, participated in the 42nd Annual Eastern Great Lakes Burn Study Group Meeting in Pittsburgh, PA held October 16-17, 2014.
MSON: 12.47 (-0.40)
New Data Reports Reduction in Blood Loss With Misonix SonicOne® O.R. In Burn Patients
PR Newswire - Mon Nov 10, 12:39PM CST
Misonix, Inc. (NasdaqGM: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced that new data on SonicOne O.R. was presented at the American Burn Association's ("ABA"
2014 Western Regional Burn Conference in Las Vegas, NV, held November 6-9, 2014. The ABA and its more than 3,500 members promote and support burn-related research, education, care, rehabilitation and prevention. MSON: 12.47 (-0.40)
Misonix (MSON) CEO Michael McManus on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 10:03PM CST
MSON: 12.47 (-0.40)
